A major £40 million investment will drive pioneering research at the University of Edinburgh, aiming to transform diagnosis and treatment for conditions such as autism, fragile X syndrome, and ADHD.
Leo Braack, Malaria Consortium’s Senior Vector Control Specialist, recounts the ongoing battle against vector-borne diseases and shares why the need for new mosquito control tools has become critical.
Dr Kristen Kroll from Washington University School of Medicine discusses new approaches for studying autism and other neurodevelopmental disorders by using human cellular models of brain development.
Black recipients of liver transplants have lower post-transplant survival rates than white or Hispanic patients, according to a new study from Keck Medicine of USC.
Dr Lynn Woods, Professor in the Department of Doctoral Programs, School of Nursing, Azusa Pacific University, explores behavioural symptoms of dementia in the Latinx population.
Professor Heather Sheardown from McMaster University provides detail about treating vision-related conditions, including injectable, in situ gelling systems.
Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
